Patent: RE37919
✉ Email this page to a colleague
Summary for Patent: RE37919
Title: | Recombinant DNA method for production of parathyroid hormone |
Abstract: | A recombinant DNA molecule coding for human parathyroid hormone operably linked to an inducible bacterial promoter, a leader growth hormone sequence, and a selective enzymatic cleavage site, expression of the molecule in bacteria, and methods for producing large quantities of human parathyroid hormone and its variants. |
Inventor(s): | Kronenberg; Henry M. (Belmont, MA), Nussbaum; Samuel R. (Weston, MA), Doi; Tomoko (Nara, JP) |
Assignee: | The General Hospital Corporation (Boston, MA) |
Application Number: | 08/790,584 |
Patent Claims: | see list of patent claims |
Details for Patent RE37919
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2009-05-12 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |